What aspirin dose should be given for preeclampsia prophylaxis in a pregnant woman at risk?

Aspirin Dose for Preeclampsia Prophylaxis

For pregnant women at high risk for preeclampsia, prescribe 81 mg of aspirin daily starting between 12-16 weeks of gestation and continuing until delivery. 1

Recommended Dosing

The standard dose is 81 mg daily, which represents the consensus recommendation across major U.S. guidelines 1, 2. While international guidelines vary slightly (WHO recommends 75 mg, NICE recommends 75-150 mg), the ACOG-endorsed approach following the 2014 USPSTF recommendation established 81 mg as the practical standard in U.S. practice 2.

Timing of Initiation

• Start between 12-16 weeks of gestation (ideally before 16 weeks) 1
• Continue until delivery 2
• Earlier initiation (before 12 weeks) may provide additional benefit, with recent evidence showing improved outcomes when started before 12 weeks compared to 12-20 weeks 3

Who Should Receive Aspirin

High-Risk Factors (any one warrants aspirin):

• History of preeclampsia, especially early-onset (<34 weeks) or in multiple pregnancies
• Chronic hypertension
• Type 1 or type 2 diabetes
• Renal disease
• Autoimmune disease (e.g., lupus, antiphospholipid syndrome)
• Multifetal gestation 2

Moderate-Risk Factors (≥2 warrant aspirin):

• First pregnancy (nulliparity)
• Maternal age ≥40 years
• BMI ≥35 kg/m²
• Family history of preeclampsia
• Pregnancy interval >10 years 2

Evidence on Dose Optimization

While 81 mg is the standard recommendation, emerging research explores whether higher doses might be more effective:

• 150 mg dosing: The ASPRE trial demonstrated that 150 mg daily reduced preterm preeclampsia by 62% in screened high-risk women 4, 5. However, this was in a highly selected population using first-trimester risk stratification.

• Dose comparison studies: Recent evidence shows conflicting results. A Swedish cohort found no difference between 150-160 mg versus 75 mg in preventing preeclampsia 6. A network meta-analysis suggested 80-100 mg may be optimal 7, while a trial in obese high-risk women showed a 78% probability of benefit with 162 mg versus 81 mg, though not definitive 8.

Clinical Bottom Line: Despite research exploring higher doses, stick with 81 mg as the evidence-based standard 1, 2. The guideline-endorsed dose has proven efficacy, established safety, and widespread acceptance. Higher doses remain investigational and are not currently recommended by major U.S. guidelines.

Efficacy and Safety

Low-dose aspirin (60-150 mg range) reduces:

• Preeclampsia risk by 24% 2
• Preterm birth by 14% 2
• Intrauterine growth restriction by 20% 2

Safety profile is favorable: No increased risk of placental abruption, postpartum hemorrhage, or fetal intracranial bleeding at recommended doses 2. The FDA label cautions against aspirin in the last trimester for analgesic purposes, but this does not apply to low-dose prophylactic use 9.

Common Pitfalls to Avoid

1. Starting too late: Aspirin works by improving placentation in early pregnancy. Starting after 20 weeks significantly reduces efficacy. Aim for 12-16 weeks 1, 3.

2. Missing moderate-risk patients: Don't forget that women with ≥2 moderate-risk factors qualify, not just those with classic high-risk conditions 2.

3. Confusing prophylactic with analgesic dosing: The 81 mg prophylactic dose is distinct from higher analgesic doses (325+ mg) that carry different risk profiles 9.

4. Stopping prematurely: Continue aspirin until delivery, not just until 36 weeks 1, 2.

5. Inadequate risk screening: Use systematic checklists to ensure no risk factors are overlooked 10.

Practical Implementation

• Assess all pregnant women for preeclampsia risk factors at the first prenatal visit
• For those meeting criteria, prescribe aspirin 81 mg daily starting at 12-16 weeks
• Document patient adherence at subsequent visits (self-reporting is standard) 1
• Continue through delivery
• Consider earlier initiation (before 12 weeks) in very high-risk patients, though this remains somewhat investigational 3